Cargando…
FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma
This cohort study examines positron emission tomography in renal cell carcinoma and its association with overall survival among adults.
Autores principales: | Ferdinandus, Justin, Maríc, Ines, Darr, Christopher, Kesch, Claudia, Bartel, Timo, Fendler, Wolfgang Peter, Grünwald, Viktor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669811/ https://www.ncbi.nlm.nih.gov/pubmed/36383385 http://dx.doi.org/10.1001/jamanetworkopen.2022.42289 |
Ejemplares similares
-
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
por: Ferdinandus, Justin, et al.
Publicado: (2022) -
Systematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patients
por: Adams, Hugo J.A., et al.
Publicado: (2019) -
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
por: Farnebo, Jacob, et al.
Publicado: (2014) -
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
por: Seifert, Robert, et al.
Publicado: (2022) -
High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy
por: Krafft, Ulrich, et al.
Publicado: (2021)